$SEIC

ROMEO CARMEN sold $548K of SEIC

ROMEO CARMEN sold 5,000 shares of SEI INVESTMENTS CO (SEIC) at $109.70 ($0.55M total) on 2026-09-01.

Original reporting
SEC EDGAR · ROMEO CARMEN
Published Sep 3, 2026, 4:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 4, 2026, 7:08 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$SEIC
Bearish
medium confidence
Mentioned
$SEIC
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$SEICBearishLow
01

Why it matters

The disclosed sale may prompt short sellers to test the stock, but overall impact is expected to be muted.

02

Market read

A modest insider sale with limited market-moving potential.

03

What to watch

Potential upcoming corporate actions or personal liquidity needs not disclosed.

Relevance 5/10Novelty 5/10Timing: filing today

Background

SEC Form 4 filing discloses insider transactions. Directors' trades are monitored for signals.

Company-level read

Ticker impact

$SEICBearishMedium confidence
Context

Director Romeo Carmen sold 5,000 shares of SEI Investments Co for $548,500 on 2026-09-01.

Expected impact

Potential short-term dip of 0.5‑1% as the market digests the sale.

Evidence & confidence

A $548k sale by a director is material enough to attract attention, yet it represents a tiny fraction of total holdings (1.56M shares).

Market effects

Minimal impact on the financial services sector; insider sales are routine.

No regional effect beyond SEI's primary market.

Limited global relevance.

Counterpoint

The sale could be a routine portfolio rebalancing rather than a lack of confidence.

Key entities

  • SEI Investments Co

    US-listed financial services firm (ticker SEIC).

  • Romeo Carmen

    Director of SEI Investments Co.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$SEICMed

SEI Investments Co (SEIC) (Q3 2026) Earnings Call Highlights: Record Sales Momentum and 24%

SEI Investments (SEIC) reported Q3 2026 earnings with 14% revenue growth, 25% adjusted operating profit growth, and 24% adjusted EPS growth. Net sales reached $47M, the second highest in company history. ETF strategies AUM grew to $9B, up from $4B last year. However, incentive compensation accrual increased by $6M, reducing operating margins. Institutional revenue declined 2% YoY, and AUM was flat sequentially. The company expects strong growth momentum in ETFs and other segments.

$SEICMed

SEI (SEIC) Q3 2026 Earnings Call Transcript

SEI (SEIC) reported strong Q3 2026 results, with growth in investment management and private banking. Demand for solutions and AI-driven services is increasing. Adjusted operating margins remained high, and the company increased incentive compensation accruals. Asset management saw momentum, with ETF strategies reaching $9B in AUM. The company also expressed confidence in its partnership with Stratos.

$SEICMedAI 8/10

What SEI Investments (SEIC) Said on Its Q3 Earnings Call

SEI Investments (SEIC) reported Q3 earnings with IMS revenue and operating profit up 14% YoY. Private banking revenue rose 11%, while operating profit increased 38%. The Advisors segment grew due to the Stratos acquisition. Institutional revenue declined 2% YoY. Margins were affected by a $6M incentive compensation accrual. SEIC ended the quarter with $400M in cash after repurchasing $215M of shares.